Pfizer, Inc. (PFE): Price and Financial Metrics

Pfizer, Inc. (PFE)

Today's Latest Price: $36.17 USD

0.22 (-0.60%)

Updated Sep 29 4:02pm

Add PFE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PFE Stock Summary

  • Pfizer Inc's market capitalization of $202,214,856,177 is ahead of 99.33% of US-listed equities.
  • PFE's went public 34.77 years ago, making it older than 92.87% of listed US stocks we're tracking.
  • The volatility of Pfizer Inc's share price is greater than that of merely 1.82% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Pfizer Inc, a group of peers worth examining would be NVS, MRK, SAP, NFLX, and T.
  • PFE's SEC filings can be seen here. And to visit Pfizer Inc's official web site, go to
PFE Daily Price Range
PFE 52-Week Price Range

PFE Stock Price Chart Technical Analysis Charts

PFE Price/Volume Stats

Current price $36.17 52-week high $40.97
Prev. close $36.39 52-week low $27.88
Day low $36.03 Volume 12,820,228
Day high $36.54 Avg. volume 28,968,318
50-day MA $37.52 Dividend yield 4.18%
200-day MA $36.40 Market Cap 200.99B

Pfizer, Inc. (PFE) Company Bio

Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about Pfizer Inc that investors may wish to consider to help them evaluate PFE as an investment opportunity.

FDA approves Pfizer's Xeljanz for polyarticular course juvenile idiopathic arthritis

Pfizer (PFE) says the FDA has approved Xeljanz (tofacitinib) for treating children/adolescents age 2 and older with active polyarticular course juvenile idiopathic arthritis ((pcJIA)). That makes the drug the only Janus kinase inhibitor approved in the U.S. for treating pcJIA. Two formulations won approval: a tablet and an oral solution,...

Seeking Alpha | September 28, 2020

Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd.

The Business Research Company offers "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it

OpenPR | September 28, 2020

Biosimilar Therapeutic Peptides Market Highlights 2020-2023 | Worldwide Top Key Players -Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc| Covid 19 Growth And Change

The Business Research Company offers " Biosimilar Therapeutic Peptides Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global

OpenPR | September 28, 2020

Dr. Fauci just said something surprising about coronavirus vaccines and face masks

Several coronavirus vaccine trials will soon be finished and some of the frontrunners might be deemed safe and effective for emergency use. Health officials from the World Health Organization and Dr. Anthony Fauci warn that the arrival of COVID-19 vaccines won't be enough to reduce the transmission of the illness anytime soon. Fauci says that precautionary measures including face masks, social distancing, and frequent handwashing will need to continue even after vaccines arrive. The FDA will host a significant coronavirus vaccine meeting in just a few weeks, at which point we might find out more details about the progress of experimental drugs that have reached the final phase of testing. Vaccine candidates from AstraZeneca/Oxford, Pfizer/BioNTech, and Moderna have Phase 3 trials underw...

BGR | September 27, 2020

The 2 Coronavirus Vaccine Stocks I'd Buy Right Now

These players -- a biotech and a pharma giant -- are leading in terms of timeline, data, and the logistics of bringing a vaccine to the masses.

Yahoo | September 27, 2020

Read More 'PFE' Stories Here

PFE Price Returns

1-mo -4.59%
3-mo 8.25%
6-mo 12.22%
1-year 4.72%
3-year 13.15%
5-year 36.70%
YTD -4.89%
2019 -6.91%
2018 24.82%
2017 15.90%
2016 4.42%
2015 7.09%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8611 seconds.